Prakiraan wutah bathi resik saben saham kanggo taun ngarep Immix Biopharma (IMMX)
Immix Biopharma, Inc. (IMMX) attracts talented scientists with a flexible startup culture, yet the lack of guaranteed success for early-stage developments and the need for secondary offerings create significant risks. This earnings per share (EPS) forecast chart helps assess the trend, where the -31.80 metric confirms the current level. The company's competitive advantage is based on patents in tissue-specific therapy and CAR-T engineering.
Rincian metrik lan analitis perusahaan Immix Biopharma, Inc. (IMMX)
- rega lan prakiraan konsensus rega:
- rincian kapitalisasi pasar:
- rincian nilai buku perusahaan:
- data liabilitas lan likuiditas perusahaan:
Utang marang Ekuitas Immix Biopharma, Inc.|IMMX - Kewajiban jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Immix Biopharma, Inc.|IMMX - Tanggungan utang total perusahaan|Utang marang nilai buku Immix Biopharma|IMMX - Gedhene kewajiban jangka dawa|Utang jangka cendhak perusahaan Immix Biopharma|Rasio cepet immixbio.com
- statistik bathi lan rasio pasar:
IMMX - Penghasilan resik perusahaan|Bathi sing dikarepake Immix Biopharma, Inc.|IMMX - Nilai perusahaan marang bathi resik|Pangali Forward P/E Immix|IMMX - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Immix Biopharma, Inc.|IMMX - Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Immix Biopharma|IMMX - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi EPS kuartalan immixbio.com|IMMX - Prakiraan wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Immix Biopharma, Inc.
- data pendapatan lan penerimaan dodolan:
Analisis kabeh metrik perusahaan:Immix Biopharma, Inc.
The indicator synthesizes current analyst estimates for earnings per share (EPS) dynamics, transforming complex discounting models into a daily trend of expected returns. This metric measures the fundamental growth potential of the business, where a positive trajectory signals market optimism regarding future cash flows. The success of Immix Biopharma, Inc. (IMMX) partnerships in the field of immunotherapy for rare cancers directly determines this forward-looking EPS growth benchmark.
Pesaing langsung
Prakiraan wutah bathi resik saben saham kanggo taun ngarep immunitybio.com|Prakiraan wutah bathi saben saham kanggo taun ngarep immunocore.com (IMCR)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Janux Therapeutics Inc (JANX)|Prakiraan wutah bathi saben saham kanggo taun ngarep Arcus Bio RCUS|Zymeworks Inc - Prakiraan wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep Tango Therapeutics Corp TNGX|IOVA - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|IMTX (immatics.com) - Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|Xencor Inc. (XNCR) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Compass Bio (CMPX)|Prakiraan wutah bathi saben saham kanggo taun ngarep REPL|LYEL - Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep IPHA (Innate Pharma, S.A.)|Proyeksi tambahing bathi saben saham ing taun ngarep PYXS|Prakiraan wutah bathi kanggo taun ngarep CGEN (Compugen Ltd.)|Dinamika bathi saben saham sing diarepake ing taun ngarep IOBT|sutrobio.com - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep MiNK Therapeutics, Inc|Werewolf (HOWL) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|ALX Oncology Holdings - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Cue Biopharma|Prakiraan wutah bathi kanggo taun ngarep pdsbiotech.com|Prakiraan wutah bathi resik saben saham kanggo taun ngarep sonnetbio.com (SONN)|MAIA: Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep|Liminatus Pharma Inc. - Prakiraan wutah bathi saben saham kanggo taun ngarep|LAVA Therapeutics N.V. (LVTX) - Prakiraan wutah bathi resik saben saham ing taun ngarep|NXTC - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|LPTX: Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Intensity Therapeutics (INTS) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Sensei Bio (SNSE)|TOVX (Theriva Biologics Inc) - Prakiraan wutah bathi kanggo taun ngarep|Gritstone bio (GRTS) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep KA|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep NexImmune Inc|Prakiraan wutah bathi resik saben saham kanggo taun ngarep turnstonebio.com TSBX|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Vaccinex Inc (VCNX)|HARP - Prakiraan wutah bathi resik saben saham kanggo taun ngarep
